fbpx

Day

September 10, 2019
Designation Underscores Urgent Need for New Antifungals Targeting Multidrug-Resistant Pathogens SAN DIEGO – Sept. 9, 2019 – Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems, announced today that the U.S. Food & Drug Administration (FDA) has granted Fast Track designations for both the intravenous (IV) and oral...

News

Can psychedelics lift the fog of depression?
5. September 2019
Studying microscopic motors in the stomach
26. August 2019
Parkinson-symptomer invaderede fra tarmsystemet
Parkinson’s symptoms invade from the gut
18. July 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge